| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88017647 | FILING DATE | 06/27/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | CALLAGHAN, BRIAN P |
L.O. ASSIGNED | 108 |
PUB INFORMATION |
|||
| RUN DATE | 03/19/2019 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 03/18/2019 | ||
| LITERAL MARK ELEMENT | DUZALLO | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | YES | 1 (a) | YES | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | YES | 44D | NO | 44D | NO |
| 44E | NO | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | DUZALLO |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | AstraZeneca AB |
| ADDRESS | Vastra Malarehamnen 9 Södertälje, SE-15185 |
| ENTITY | 99-aktiebolag (ab) |
| CITIZENSHIP | Sweden |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations and substances for use in the treatment of hyperuricemia associated with gout |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 10/06/2017 | FIRST USE IN COMMERCE DATE | 10/06/2017 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | Color is not claimed as a feature of the mark. |
| DESCRIPTION OF MARK | The mark consists of two interlocking rhombi with rounded corners positioned to the left of and level with the term "DUZALLO". |
| OWNER OF US REG NOS | 5239241 |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON European Union |
| APPLICATION NO. | 017897952 |
| APPLICATION FILING DATE | 05/09/2018 |
| FOREIGN REG NO. | 017897952 |
| FOREIGN REG DATE | 08/31/2018 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | 05/09/2028 |
| FOREIGN EXPIRATION | 05/09/2028 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 03/18/2019 | DMCC | I | DATA MODIFICATION COMPLETED | 018 |
| 03/18/2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 017 |
| 03/16/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 016 |
| 03/16/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 015 |
| 03/15/2019 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 014 |
| 03/03/2019 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 013 |
| 03/03/2019 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | 012 |
| 03/03/2019 | CNSI | R | SUSPENSION INQUIRY WRITTEN | 011 |
| 03/01/2019 | RCCK | S | LIE CHECKED SUSP - TO ATTY FOR ACTION | 010 |
| 02/28/2019 | ALIE | A | ASSIGNED TO LIE | 009 |
| 02/08/2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 008 |
| 08/06/2018 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 007 |
| 08/06/2018 | GNSL | F | LETTER OF SUSPENSION E-MAILED | 006 |
| 08/06/2018 | CNSL | R | SUSPENSION LETTER WRITTEN | 005 |
| 08/06/2018 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 07/03/2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 07/02/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 06/30/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Wm. Charles Saunders |
| CORRESPONDENCE ADDRESS | WM. CHARLES SAUNDERS ASTRAZENECA PHARMACEUTICALS LP 1800 CONCORD PIKE A2C WILMINGTON, DE 19850-5437 |
| DOMESTIC REPRESENTATIVE | NONE |